| Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637) |
|---|
| 01/18/2011 | US7871986 provides a prostate specific antigen oligo-epitope peptide (PSA-OP) that is useful as an immunogen in the prevention or treatment of prostatic cancer and in the inhibition of prostatic cancer cells and in the establishment and characterization of PSA-specific cytotoxic T-cell lines |
| 01/18/2011 | US7871814 Recombinant bicistronic flaviviruses and methods of use thereof |
| 01/18/2011 | US7871807 under any circumstances, in a short period of time and in large amount; vaccine; immunizing a hen by administering a flu vaccine to hen to trigger embryogenesis in its eggs, infecting the embryonated eggs by inoculating a flu virus into the allantoic cavity, incubating, harvesting the allantoic fluid |
| 01/13/2011 | WO2011004146A1 Chimaeric protein |
| 01/13/2011 | WO2011003194A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | WO2011003191A1 Compositions and methods for enhancing virus efficacy |
| 01/13/2011 | WO2010123200A3 Bacteriophage which kills pathogenic enteric bacteria |
| 01/13/2011 | WO2010105020A3 Baculoviruses with enhanced virion production and a method for the production of baculoviruses |
| 01/13/2011 | WO2010099960A3 Assembly activating protein (aap) and its use for the manufacture of parvovirus particles essential consisting of vp3 |
| 01/13/2011 | US20110008873 Purified bacteriophage, its preparation and application |
| 01/13/2011 | US20110008872 Immortalized Avian Cell Lines |
| 01/13/2011 | US20110008871 Production of Homogeneous Cell Line Highly Permissive To Porcine Circovirus Type 2 (PCV2) Infection |
| 01/13/2011 | US20110008387 Composition containing hcmv particles |
| 01/13/2011 | US20110008386 Use of mva to treat prostate cancer |
| 01/13/2011 | US20110008384 Antiviral activity from medicinal mushrooms |
| 01/13/2011 | US20110008351 Anticomplement polypeptides of ixodes ricinus |
| 01/13/2011 | US20110008295 Simian adenoviruses sadv-36, -42.1, -42.2, and -44 and uses thereof |
| 01/13/2011 | US20110008288 Hepatitis c virus inhibitors |
| 01/13/2011 | CA2767561A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/13/2011 | CA2767392A1 Methods for preparing vesicles and formulations produced therefrom |
| 01/13/2011 | CA2767207A1 Bioprocessing |
| 01/13/2011 | CA2765066A1 Compositions and methods for enhancing virus efficacy |
| 01/12/2011 | EP2272950A2 Defective influenza virus particles |
| 01/12/2011 | EP2272949A2 Infectious bursal disease virus antigenic isolates and vaccines |
| 01/12/2011 | EP2272859A2 Immunological herpes simplex virus antigens and methods for use thereof |
| 01/12/2011 | EP2272532A2 Rotavirus vaccine |
| 01/12/2011 | EP2272525A2 Adjuvant viral particle |
| 01/12/2011 | EP2271663A1 Novel avian astrovirus |
| 01/12/2011 | EP1644034B1 Composition for enhancing an immune response comprising packaged virus-like particles |
| 01/12/2011 | CN101942425A Enzyme related to benzalacetone synthesis, coding gene and application thereof |
| 01/12/2011 | CN101942424A Coding gene of UDP (Uridine Diphosphate)-glucosyltransferase mutant and application thereof |
| 01/12/2011 | CN101942419A Dog parvovirus attenuated vaccine strain and application thereof |
| 01/12/2011 | CN101942418A 333rd amino acid mutant strain of rabies virus Flury-LEP glycoprotein |
| 01/12/2011 | CN101942417A Separated bacteriophages of enterobacter sakazakii, combination and application thereof |
| 01/12/2011 | CN101940787A Adjuvant for improving effect of porcine reproductive and respiratory syndrome inactivated vaccine, preparation method thereof and application thereof |
| 01/12/2011 | CN101560503B Influenza A virus Vero cell adapted strain and application thereof |
| 01/11/2011 | US7867982 administering to a primate(human) an immunogenic composition containing modified virus Ankara (MVA), a replication-deficient strain of vaccinia virus, expressing human immunodeficiency virus (HIV) env, gag, and pol genes to induce a CD8+T cell immune |
| 01/10/2011 | CA2709340A1 Mutations in the influenza a virus ns1 gene and use thereof |
| 01/10/2011 | CA2709292A1 Oncolytic viruses and methods for treating neoplastic disorders |
| 01/06/2011 | WO2011002522A2 Methods of making and using synthetic viruses |
| 01/06/2011 | WO2011000058A1 A method of preparation of a biological particulate structure |
| 01/06/2011 | WO2010125196A3 Bacteriophages specific to pak and cha strains of pseudomonas aeruginosa and their applications |
| 01/06/2011 | WO2010096249A3 Solenopsis invicta virus |
| 01/06/2011 | US20110003697 Plant myb transcription factor homologs |
| 01/06/2011 | US20110003381 Viral vectors and host cells and methods of making and using them |
| 01/06/2011 | US20110003278 H5 Subtype-Specific Binding Proteins Useful for H5 Avian Influenza Diagnosis and Surveillance |
| 01/06/2011 | US20110002960 Influenza hemagglutinin and neuraminidase variants |
| 01/06/2011 | US20110002959 Vaccine Production For Pathogenic Bird Viral Diseases |
| 01/06/2011 | US20110002943 Use of enterovirus for diagnostics, treatment and prevention of disease |
| 01/06/2011 | US20110002910 Therapeutic agents comprising pro-apoptotic proteins |
| 01/05/2011 | EP2270040A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 01/05/2011 | EP2270027A1 Polypeptides having brain-localizing activity and uses thereof |
| 01/05/2011 | EP2269637A1 Influenza Vaccine |
| 01/05/2011 | EP2269619A1 Methods and compositions concerning poxviruses and cancer |
| 01/05/2011 | EP2269618A1 An oncolytic vaccinia virus for use in combination with a chemotherapy for treating cancer. |
| 01/05/2011 | EP2268801A2 Compositions and processes relating to human bocavirus |
| 01/05/2011 | EP2268800A1 A newly identified human rhinovirus of hrv-c and methods and kits for detecting hrv-cs |
| 01/05/2011 | EP2268799A2 Reducing conjugative plasmids in bacteria |
| 01/05/2011 | CN101939419A Recombinant BCG tuberculosis vaccine for eliciting immune responses to mycobacterium tuberculosis |
| 01/05/2011 | CN101935676A Method for inducing in-vitro transformation of scallop tissue cells |
| 01/05/2011 | CN101935675A Construction and application of cell membrane expression ALV-env fluorescin eukaryotic transgenic expression plasmid |
| 01/05/2011 | CN101935671A Method for constructing adenovirus core protein genetic marker vector |
| 01/05/2011 | CN101935637A Recombinant low-virulent vaccine strain of chicken infectious bursal disease viruses (IBDV) and application thereof |
| 01/05/2011 | CN101935636A T cell receptor display |
| 01/05/2011 | CN101935634A Clonal strain of cabbage looper cell line and application thereof |
| 01/05/2011 | CN101934074A Porcine circovirus II vaccine and production method thereof |
| 01/04/2011 | US7862821 Recombinant vaccine against bluetongue virus |
| 01/04/2011 | CA2401545C Mutated cyclin g1 protein |
| 01/04/2011 | CA2392075C Method for the preparation of purified hcv rna by exosome separation |
| 01/04/2011 | CA2388301C Modified gp100 and uses thereof |
| 01/04/2011 | CA2350127C Avipox vector coding an hiv antigen and a cytokine |
| 12/30/2010 | US20100330666 Vectors and Methods for Tissue Specific Synthesis of Protein in Eggs of Transgenic Hens |
| 12/30/2010 | US20100330650 Recombinant vaccine against japanese encephalitis virus [jev] infection and a method thereof |
| 12/30/2010 | US20100330121 Recombinant alphavirus-based vectors with reduced inhibition of cellular macro-molecular synthesis |
| 12/30/2010 | US20100330120 Human parainfluenza viruses having separated p and c genes |
| 12/30/2010 | US20100330118 Influenza hemagglutinin and neuraminidase variants |
| 12/30/2010 | US20100330038 Methods for expressing proteins in axons |
| 12/30/2010 | US20100330037 Adenoviral systems and the uses thereof |
| 12/29/2010 | WO2010151673A1 Swine influenza hemagglutinin variants |
| 12/29/2010 | WO2010150017A1 Tangential flow filtration of viruses with reverse flow |
| 12/29/2010 | WO2010148511A1 Chimeric influenza virus-like particles comprising hemagglutinin |
| 12/29/2010 | EP2267120A1 Recombinant vaccinia virus having hepatitis c virus gene |
| 12/29/2010 | EP2267119A1 Method for concentration of virus |
| 12/29/2010 | EP2267020A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267019A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267018A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267017A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267016A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2267015A2 Binding polypeptides for B lymphocyte stimulator protein (BLyS) |
| 12/29/2010 | EP2266675A2 Chromatography medium, preparation method of the same, and method for producing virus vaccine using the chromatography medium |
| 12/29/2010 | EP2265284A2 Replication-defective flavivirus vaccines and vaccine vectors |
| 12/29/2010 | EP1425305B1 Igf-1 as feline vaccine adjuvant, in particular against feline retroviruses |
| 12/29/2010 | CN1934131B Optimized expression of hpv 52 l1 in yeast |
| 12/29/2010 | CN101932700A Methods and compositions for immunizing pigs against porcine circovirus |
| 12/29/2010 | CN101932595A Phage phi-mru polynucleotides and polypeptides and uses thereof |
| 12/29/2010 | CN101928727A Newcastle disease virus Italien strain auxiliary expression plasmid systems, micro genome for detecting system and application thereof |
| 12/29/2010 | CN101928697A High-efficiency and rapid water environment virus enrichment method |
| 12/29/2010 | CN101928696A Preparation and application of prostate cancer targeting adenovirus |
| 12/29/2010 | CN101928345A Human source antibody and humanization remolding method thereof |
| 12/29/2010 | CN101926992A Recombined attenuated live vaccine for preventing and treating I-type or II-type infection of herpes simplex virus and preparation method thereof |